Sources of Biopharmaceutical Innovation: An Assessment of Intellectual Property
Economic Research Working Paper No. 24
Auteur(s): Michael S. Kinch, Julio Raffo | Année de publication: 2015
An analysis of new, FDA-approved molecular entities reveals dynamism in terms of new innovation. An assessment of the first patent for each drug reveals that the pharmaceutical industry, particularly large, established companies in North America, tend to dominate the field. Whereas inventors continue to found biotechnology companies at a steady rate, recent trends suggest these inventors more often come from the private sector.